What’s making the PolarityTE, Inc. (PTE) stock to boost in premarket?
PolarityTE, Inc. (PTE) has seen a push of 7.64% in the premarket after the company announced updates on FDA Approval of IND for Pivotal Phase 3 Study of SkinTE. However, the last trading session closed at $0.7199 with a decrease of 1.06%. FDA Approval of IND for Pivotal Phase 3 Study On 18th January 2022, […]